Menten AI

Menten AI designs peptide and protein therapeutics using quantum…

San Francisco, United States · $3.8M raised

Employees
1–10
Website
menten.ai
Total Funding
$3.8M
Last Round
$3.6M SeedJun 2020
Rounds
3

About

Menten AI designs protein drugs and enzymes using quantum computing and machine learning. Their technology leapfrogs current computational methods making it possible to design previously intractable proteins. The team created the first protein design algorithm for current and near-term quantum computers and created the world’s first protein designed on a quantum computer. They are now working on 3 new proteins, including a peptide to prevent the spread of viruses like Covid-19. They have 2 paid pilot projects with multinational chemical companies and 4 LOI’s with pharma and biotech companies.

Summary

Menten AI is a Drug Discovery company based in San Francisco, United States. It has raised $3.8M in total across 3 rounds, most recently a $3.6M Seed round in Jun 2020. Investors include Uncork Capital, Khosla Ventures and Y Combinator Continuity Fund.

Tech & App Stack

4 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed RoundJun 2020
$3.6M

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies